(Q45217488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Absence of V599E BRAF mutations in desmoplastic melanomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author

Mohammad Obaidul Hoque

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

6

David Sidransky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

7

William H Westra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Jon M Davison

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Eli Rosenbaum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Terry L Barrett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

David Goldenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

788-792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15641040%20AND%20SRC:MED&resulttype=core&format=json

Determinants of BRAF mutations in primary melanomas

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

The clinical behavior of desmoplastic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

High BRAF mutation frequency does not characterize all melanocytic tumor types.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

BRAF point mutations in primary melanoma show different prevalences by subtype.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

The Raf/MEK/ERK pathway: new concepts of activation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Loss of genes on the short arm of chromosome 11 in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Lack of BRAF mutation in primary uveal melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Absence of BRAF mutations in UV-protected mucosal melanomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Morphological and immunophenotypic variations in malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021

Pharmacological inhibitors of MAPK pathways.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20861

7 January 2021